Verrica Pharmaceuticals Inc. Related Party Transaction, Amounts of Transaction
Verrica Pharmaceuticals Inc. (VRCA) reported Related Party Transaction, Amounts of Transaction of $76.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. related party transaction, amounts of transaction for the quarter ending 2026-06-30 was $76.00K, a 10.14% increase year-over-year.
- Verrica Pharmaceuticals Inc. related party transaction, amounts of transaction for the quarter ending 2026-03-31 was $108.00K, a 89.47% increase year-over-year.
- Verrica Pharmaceuticals Inc. related party transaction, amounts of transaction for the quarter ending 2025-06-30 was $69.00K.
- Verrica Pharmaceuticals Inc. related party transaction, amounts of transaction for the quarter ending 2025-03-31 was $57.00K.
- Verrica Pharmaceuticals Inc. related party transaction, amounts of transaction for fiscal 2025 was $400.00K, a 393.83% increase from fiscal 2024.
- Verrica Pharmaceuticals Inc. related party transaction, amounts of transaction for fiscal 2024 was $81.00K.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|
| 2026-06-30 | $76.00K 10-Q · filed 2026-08-06 | $184.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $108.00K 10-Q · filed 2026-05-12 | ||
| 2025-12-31 | $400.00K 10-K · filed 2026-03-11 | ||
| 2025-06-30 | $69.00K 10-Q · filed 2026-08-06 | $126.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $57.00K 10-Q · filed 2026-05-12 | ||
| 2024-12-31 | $81.00K 10-K · filed 2026-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |